Evidence map›Paper›PMID 35011255›Full record

ArticleMolecules (Basel, Switzerland)2021

In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against

Maciej Spiegel, Paweł Krzyżek, Ewa Dworniczek, Ryszard Adamski, Zbigniew Sroka

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
  3. Natural products for biocontrol ofFrontiers in plant science · 2026
    Review
  4. Article
  5. Novel Insights into the Therapeutic Effect of Amentoflavone AgainstInternational journal of molecular sciences · 2025
    Article
  6. Optimization ofInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Infection and drug resistance · 2022
    Review
  12. Biofilm Formation ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maciej SpiegelDepartment of Pharmacognosy and Herbal Medicines, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.ORCID 0000-0002-8012-1026
Paweł KrzyżekDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chalubinskiego 4, 50-368 Wroclaw, Poland.ORCID 0000-0002-3117-8894
Ewa DworniczekDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chalubinskiego 4, 50-368 Wroclaw, Poland.
Ryszard AdamskiLaboratory of Microscopic Techniques, Institute of Genetics and Microbiology, University of Wroclaw, Przybyszewskiego 63, 50-001 Wroclaw, Poland.
Zbigniew SrokaDepartment of Pharmacognosy and Herbal Medicines, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.ORCID 0000-0001-6618-017X
Wroclaw Medical University · PLUniversity of Wrocław · PL

Funding

National Centre for Research and Development IA/SP/453975/2020Wrocław Medical University SUB.A130.19.021Wrocław Medical University SUB.A130.21.031
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBiofilmsBiological ProductsCatalytic DomainClarithromycinDiosgeninDrug Evaluation, PreclinicalHelicobacter InfectionsHelicobacter pyloriHumansLevofloxacinMetronidazoleMicrobial Sensitivity TestsMolecular Docking SimulationProtein BindingAnti-Bacterial AgentsBiological ProductsClarithromycindioscinDiosgeninLevofloxacinMetronidazolePyrophosphatasesalternative therapybiofilmBiofluxcoccoid formsdioscinHelicobacter pylorimolecular dockingphytotherapyvirulence

Identifiers

PMID35011255
PMCPMC8746548
OpenAlexW4200089884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.